Associate Professor at National Research Centre, Egypt
Dr. Ahmed A. Abd-Rabou is a distinguished Associate Professor of Medical Biochemistry at the National Research Centre (NRC), Egypt, with a robust portfolio in medical sciences, nanotechnology, and cancer biology. His scholarly achievements have been recognized through multiple national and international awards. He earned his Ph.D. in Biochemistry from Cairo University, with academic endorsement from the University of Rostock in Germany and the University of Hong Kong, reflecting his international academic engagement. Dr. Abd-Rabou’s postdoctoral research at INSERM in France and his fellowship at ACPHS in the USA are a testament to his global scientific contributions, particularly in molecular therapeutics and nano-drug delivery systems. With an H-index of 23, his research has significantly advanced the understanding of apoptosis in cancer and stem cell-based therapies.
Profile
Scopus
Education
Dr. Abd-Rabou began his academic journey with a B.Sc. in Biochemistry and Chemistry from Ain Shams University in 2007, graduating with honors and top rank in his class. He pursued his M.Sc. in Biochemistry and Molecular Biology at Cairo University, completed in 2011, and further advanced to a Ph.D. in the same field in 2015. His doctoral work was validated by prominent global institutions, including Rostock University and the University of Hong Kong, and examined by renowned figures such as Prof. Nadia Zakhary and Prof. Josef Brock. These achievements laid a solid foundation for his continued impact in biomedical research.
Experience
Dr. Abd-Rabou has held numerous positions at the NRC since 2008, ascending from Specialist to his current role as Associate Professor. He has been actively involved in auditing and research oversight, serving on the Medical Division Internal Audit ISO team and the Hormones Department Board. His roles include being a core member of the Stem Cell Laboratory at the Advanced Centre of Medical Research and participating in several collaborative initiatives. Internationally, he completed a postdoctoral fellowship at INSERM in France (2016) and a fellowship in nano-drug delivery at ACPHS, New York (2013–2014), strengthening his expertise in nanomedicine and cancer therapeutics.
Research Interest
Dr. Abd-Rabou’s research is focused on medical biochemistry, with particular emphasis on apoptosis, cancer therapy, nanotechnology, and stem cell applications. His work explores molecular mechanisms of drug resistance in cancer, the role of TRAIL and thymoquinone in apoptosis, and mesenchymal stem cells’ therapeutic potential in neurological disorders. His interdisciplinary approach integrates nanotechnology with molecular biology, aiming to design targeted treatments that address the limitations of conventional therapies.
Awards
Dr. Abd-Rabou has received several prestigious awards that highlight his excellence in research. In 2023, he was honored with the National Prize of Excellence in Medical Science, a testament to his influence in the field. He previously earned the NRC Prize for Nanotechnology and Biological Applications in 2019 and the NRC Award for Highest Publications in 2016. His academic excellence was also recognized by the Egyptian Ministry of Defense during his B.Sc. and M.Sc. studies. These accolades underscore his sustained contributions to scientific advancement and innovation in biomedical sciences.
Publications
Dr. Abd-Rabou has published extensively in peer-reviewed journals, with impactful research cited globally. Selected publications include:
- Ahmed A. Abd-Rabou et al. (2022). “TRAIL-loaded nanoparticles overcome breast cancer drug resistance via apoptosis induction.” Biomaterials Science. Cited by 45 articles.
- Ahmed A. Abd-Rabou et al. (2021). “Stem cell-based therapy in temporal lobe epilepsy models.” Cellular and Molecular Neurobiology. Cited by 28 articles.
- Ahmed A. Abd-Rabou et al. (2020). “Nanomedicine approaches in tumor microenvironment modulation.” International Journal of Nanomedicine. Cited by 53 articles.
- Ahmed A. Abd-Rabou et al. (2019). “Role of thymoquinone in cancer apoptosis pathways.” Journal of Biochemical Pharmacology. Cited by 61 articles.
- Ahmed A. Abd-Rabou et al. (2018). “Molecular markers of breast cancer stemness.” Journal of Cellular Physiology. Cited by 36 articles.
- Ahmed A. Abd-Rabou et al. (2017). “Nanotechnology in targeting cancer stem cells.” Cancer Letters. Cited by 48 articles.
- Ahmed A. Abd-Rabou et al. (2016). “Functionalization of TNF-Related Ligands in Cancer Nanotherapy.” European Journal of Pharmaceutical Sciences. Cited by 52 articles.
Conclusion
Dr. Ahmed A. Abd-Rabou is an exemplary candidate for prestigious research recognition due to his unwavering commitment to advancing medical biochemistry. His academic and professional journey reflects a deep dedication to integrating cutting-edge nanotechnology with therapeutic strategies against cancer and neurological diseases. His ability to bridge international research standards, supervise future scientists, and contribute meaningfully to national and global health innovations positions him as a leader in the scientific community. Through his diverse roles and impactful publications, Dr. Abd-Rabou has consistently demonstrated excellence, innovation, and a drive for translational research that benefits society at large.